First example of phosphoramidate approach applied to a 4 '-substituted purine nucleoside (4 '-azidoadenosine): conversion of an inactive nucleoside to a …

P Perrone, F Daverio, R Valente… - Journal of medicinal …, 2007 - ACS Publications
We report on the synthesis of the anti hepatitis C virus (HCV) agent 4 '-azidoadenosine (1)
and the application of the phosphoramidate ProTide technology to this nucleoside. The …
被引用次数：95 相关文章

[引用][C] First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): Conversion of an inactive nucleoside to a …

P PERRONE, F DAVERIO… - Journal of medicinal …, 2007 - pascal-francis.inist.fr
First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine)
: Conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C …

[引用][C] First Example of Phosphoramidate Approach Applied to a 4 '-Substituted Purine Nucleoside (4 '-Azidoadenosine): Conversion of an Inactive Nucleoside to a …

P Perrone, F Daverio, R Valente, S Rajyaguru… - Journal of Medicinal …, 2007 - cir.nii.ac.jp
First Example of Phosphoramidate Approach Applied to a 4‘-Substituted Purine Nucleoside (4‘-Azidoadenosine):
Conversion of an Inactive Nucleoside to a Submicromolar Compound versus Hepatitis C …

[引用][C] First Example of Phosphoramidate Approach Applied to a 4 '-Substituted Purine Nucleoside (4 '-Azidoadenosine): Conversion of an Inactive Nucleoside to a …

P Perrone, F Daverio, R Valente, S Rajyaguru… - Journal of Medicinal …, 2007 - infona.pl
First Example of Phosphoramidate Approach Applied to a 4‘-Substituted Purine Nucleoside (4‘-Azidoadenosine):
Conversion of an Inactive Nucleoside to a Submicromolar Compound versus Hepatitis C …

First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a …

P Perrone, F Daverio, R Valente… - Journal of Medicinal …, 2007 - europepmc.org
We report on the synthesis of the anti hepatitis C virus (HCV) agent 4'-azidoadenosine (1)
and the application of the phosphoramidate ProTide technology to this nucleoside. The …

First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): Conversion of an inactive nucleoside to a …

P Perrone, F Daverio, R Valente… - Journal of Medicinal …, 2007 - orca.cardiff.ac.uk
First example of phosphoramidate approach applied to a 4 '-substituted purine nucleoside (4
'-azidoadenosine): Conversion of an inactive nucleoside to a submicromolar compound versus …

First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a …

P Perrone, F Daverio, R Valente… - Journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
We report on the synthesis of the anti hepatitis C virus (HCV) agent 4'-azidoadenosine (1)
and the application of the phosphoramidate ProTide technology to this nucleoside. The …

First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): Conversion of an inactive nucleoside to a …

P Perrone, F Daverio, R Valente… - Journal of Medicinal …, 2007 - orca.cardiff.ac.uk
First example of phosphoramidate approach applied to a 4 '-substituted purine nucleoside (4
'-azidoadenosine): Conversion of an inactive nucleoside to a submicromolar compound versus …